{pboot:sort scode=} [sort:name]
{/pboot:sort}

  • Application of Synthetic Biology-Based Novel Ingredients

    Synthetic biology-based novel ingredients offer new possibilities across multiple fields, including biomedicine, medical aesthetics, and cosmetic skincare. In the medical aesthetics sector, research is conducted on the process development and product innovation of new aesthetic ingredients, exploring the application potential of independently developed solutions. This aims to provide clients with novel medical aesthetic ingredients that exhibit superior biocompatibility, enhanced functionality, and adaptability, better integrate with tissue environments, and deliver immediate, high-efficiency results.

  • Medical Aesthetic Ingredient Molecular Design Platform‌

    Rational design and modification of existing medical aesthetics ingredients, leveraging techniques such as bioinformatics, protein engineering, enzyme engineering, and molecular biology, to achieve new functional empowerment and enhance application accessibility through engineering means, or to discover novel functional ingredients through full rational design of entirely new artificial material molecules, thereby expanding new directions and fields for the application of medical aesthetics ingredients.

  • Medical Aesthetic Bionic Tissue Engineering Platform

    The Bionic Tissue Engineering Platform integrates the company's technical expertise in genetic engineering and material preparation to perform bionic design of aesthetic materials from both compositional and structural perspectives. By utilizing raw materials produced through genetic recombination that match the composition of target tissues, the platform achieves bionic value. Material filling based on this approach can sculpt ideal contours while inducing cell spreading, migration, proliferation, and differentiation, thereby accelerating facial tissue repair and reconstruction and delivering aesthetic shaping effects.

  • Medical Aesthetic New Material Product Development Platform

    The Medical Aesthetic New Material Product Development Platform is dedicated to the research, development, registration, and production of specialized aesthetic products, primarily based on recombinant collagen, polysaccharides, and their composite materials. Leveraging proprietary processing techniques such as freeze-drying and cross-linking, along with an innovative new material application technology platform for medical aesthetics, the platform conducts comprehensive development processes spanning from small-scale and pilot-scale research to registration testing, clinical trials, registration submissions, and production licensing. This enables the commercialization of the company's proprietary new materials for medical aesthetics.